Bulletin
Investor Alert

Zogenix Inc.

NAS: ZGNX

GO
/marketstate/country/us

After Hours

/zigman2/quotes/204255718/composite

$

24.21

Change

0.00 0.00%

Volume

Volume 62,359

Sep 18, 2020, 4:32 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/204255718/composite

Previous close

$ 24.37

$ 24.21

Change

-0.16 -0.66%

Day low

Day high

$23.63

$24.67

Open
Open: 24.67

52 week low

52 week high

$16.65

$57.22

Open

Market cap

$1.34B

Average volume

741,840

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-9.51

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/zgnx

MarketWatch News on ZGNX

  1. GW Pharmaceuticals, Momenta Pharmaceuticals and Zogenix all started at market perform at Raymond James

    8:17 a.m. Aug. 25, 2020

    - Tonya Garcia

  2. Zogenix's shares rise on FDA approval of seizure drug

    9:07 a.m. June 29, 2020

    - Jaimy Lee

  3. Zogenix stock price target cut to $55 from $64 at Mizuho

    5:59 a.m. June 29, 2020

    - Tomi Kilgore

  4. Zogenix reiterated as outperform at Leerink

    8:41 a.m. Dec. 10, 2019

    - Ciara Linnane

  5. Boeing Stock Falls, KB Home Rises, and the Dow Is Flat

    9:28 a.m. June 27, 2019

    - Barron's Online

  6. Zogenix stock drops 25% after FDA rejects filing

    4:42 p.m. April 8, 2019

    - Wallace Witkowski

  7. Zogenix started at buy with $116 stock price target at B. Riley FBR

    9:25 a.m. Sept. 7, 2018

    - Tomi Kilgore

  8. How to make, and avoid losing, money with marijuana stocks

    3:01 p.m. July 24, 2018

    - Nigam Arora

  9. Charting the Market

    9:51 p.m. July 13, 2018

    - Barron's Online

  10. Zogenix reports positive results in trial of treatment for severe epilepsy disease Dravet syndrome

    7:11 a.m. July 12, 2018

    - Ciara Linnane

  11. Zogenix shares soar 14% premarket

    7:12 a.m. July 12, 2018

    - Ciara Linnane

  12. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/zgnx

Other News on ZGNX

  1. Zogenix (ZGNX) Receives a Buy from Needham

    12:48 p.m. Aug. 6, 2020

    - SmarterAnalyst

  2. Zogenix (ZGNX) Reports Q2 Loss, Misses Revenue Estimates

    10:15 p.m. Aug. 5, 2020

    - Zacks.com

  3. Zogenix: A Critical Launch

    7:58 a.m. July 6, 2020

    - Seeking Alpha

  4. Zogenix's Long-Awaited Drug Approved With a Warning

    1:45 p.m. July 5, 2020

    - GuruFocus.com

  5. Zogenix (ZGNX) in Focus: Stock Moves 7.6% Higher

    8:53 a.m. July 2, 2020

    - Zacks.com

  6. Needham Assigns a Buy Rating on Zogenix (ZGNX)

    6:00 a.m. June 29, 2020

    - SmarterAnalyst

  7. Zogenix on wild ride after FDA Fintepla nod

    12:50 p.m. June 26, 2020

    - Seeking Alpha

  8. Zogenix Gets FDA Nod for Dravet Syndrome Seizure Treatment

    10:48 a.m. June 26, 2020

    - Zacks.com

  9. Loading more headlines...
/news/pressrelease/company/us/zgnx

Press Releases on ZGNX

  1. Zogenix Inc Down 11.4% Since SmarTrend Downtrend Call (ZGNX)

    1:26 a.m. Aug. 25, 2020

    - Comtex SmarTrend(R)

  2. Global Needle-Free Drug Injection Systems Industry

    11:20 a.m. July 14, 2020

    - PR Newswire - PRF

  3. Friday's ETF with Unusual Volume: XPH

    12:01 p.m. June 26, 2020

    - MarketNewsVideo.com

  4. Loading more headlines...

Rates »

Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.